v3.25.4
Document and Entity Information
Dec. 05, 2025
Document And Entity Information [Line Items]  
Document Type 8-K/A
Amendment Flag true
Document Period End Date Dec. 05, 2025
Entity Registrant Name CENTESSA PHARMACEUTICALS PLC
Entity Incorporation State Country Code X0
Entity File Number 001-40445
Entity Tax Identification Number 98-1612294
Entity Address Address Line 1 3rd Floor
Entity Address Address Line 2 1 Ashley Road
Entity Address Address Line 3 Altrincham
Entity Address City Or Town Cheshire
Entity Address Postal Zip Code WA14 2DT
Entity Address Country GB
Country Region +1
City Area Code 617
Local Phone Number 468-5770
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Entity Ex Transition Period false
Amendment Description This filing amends Item 5.02 of the Current Report on Form 8-K of Centessa Pharmaceuticals plc (the “Company” or “Centessa”) filed on December 11, 2025 (the “Original Form 8-K”) to add the information described below. No other changes are being made to the Original Form 8-K.
Entity Central Index Key 0001847903
Ordinary shares, nominal value £0.002 per share [Member]  
Document And Entity Information [Line Items]  
Security 12b Title Ordinary shares, nominal value £0.002 per share
Trading Symbol CNTA
Security Exchange Name NASDAQ
American Depositary Shares, each representing one ordinary share, nominal value £0.002 per share [Member]  
Document And Entity Information [Line Items]  
Security 12b Title American Depositary Shares, each representing one ordinary share, nominal value £0.002 per share
Trading Symbol CNTA
Security Exchange Name NASDAQ